An Overview of Insulin Pumps and Glucose Sensors for the Generalist

Author:

McAdams Brooke1,Rizvi Ali2

Affiliation:

1. Fellow in Endocrinology, University of South Carolina School of Medicine, Columbia, SC 29203, USA

2. Medicine and Director, Endocrinology Division, University of South Carolina School of Medicine, Two Medical Park, Suite 502, Columbia, SC 29203, USA

Abstract

Continuous subcutaneous insulin, or the insulin pump, has gained popularity and sophistication as a near-physiologic programmable method of insulin delivery that is flexible and lifestyle-friendly. The introduction of continuous monitoring with glucose sensors provides unprecedented access to, and prediction of, a patient’s blood glucose levels. Efforts are underway to integrate the two technologies, from “sensor-augmented” and “sensor-driven” pumps to a fully-automated and independent sensing-and-delivery system. Implantable pumps and an early-phase “bionic pancreas” are also in active development. Fine-tuned “pancreas replacement” promises to be one of the many avenues that offers hope for individuals suffering from diabetes. Although endocrinologists and diabetes specialists will continue to maintain expertise in this field, it behooves the primary care physician to have a working knowledge of insulin pumps and sensors to ensure optimal clinical care and decision-making for their patients.

Publisher

MDPI AG

Reference40 articles.

1. IDF diabetes atlas: Global estimates of the prevalence of diabetes for 2011 and 2030;Whiting;Diabetes Res. Clin. Pract.,1999

2. Continuous subcutaneous insulin infusion with short-acting insulin analogues or human regular insulin: Efficacy, safety, quality of life, and cost-effectiveness;Radermecker;Diabetes Metab. Res. Rev.,2004

3. Ambulatory diabetes management with pulsed subcutaneous insulin using a portable pump;Riley;Clin. Pediatrics (Phila),1980

4. Diabetes Self Management Insulin Pumps (updated June 20, 2014). Available online http://www.diabetesselfmanagement.com/diabetes-resources/tools-tech/insulin-pumps/.

5. Switching from multiple daily injections to CSII pump therapy: Insulin expenditures in type 2 diabetes;David;Am. J. Manag. Care,2014

Cited by 105 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.7亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2025 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3